Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Julen Goikolea

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
The Journal of Steroid Biochemistry and Molecular Biology|March 18, 2019
Alterations in cholesterol metabolism as a risk factor for developing Alzheimer's disease: Potential novel targets for treatmentRaúl Loera-Valencia, Julen Goikolea, Cristina Parrado-Fernandez, et al.
Journal of Virology|February 13, 2015
Triatoma virus recombinant VP4 protein induces membrane permeability through dynamic poresRubén Sánchez-Eugenia, Julen Goikolea, David Gil-Cartón, et al.
Molecular Psychiatry|September 15, 2019
Thioredoxin-80 protects against amyloid-beta pathology through autophagic-lysosomal pathway regulationGorka Gerenu, Torbjörn Persson, Julen Goikolea, et al.
The Journal of Steroid Biochemistry and Molecular Biology|August 30, 2023
Different effects of CYP27A1 and CYP7B1 on cognitive function: Two mouse models in comparisonJulen Goikolea, Maria Latorre-Leal, Christina Tsagkogianni, et al.
Alzheimer'S Research & Therapy|February 25, 2022
Serum Thioredoxin-80 is associated with age, ApoE4, and neuropathological biomarkers in Alzheimer's disease: a potential early sign of ADJulen Goikolea, Gorka Gerenu, Makrina Daniilidou, et al.
Alzheimer'S Research & Therapy|March 7, 2021
27-Hydroxycholesterol, cognition, and brain imaging markers in the FINGER randomized controlled trialAnna Sandebring-Matton, Julen Goikolea, Ingemar Björkhem, et al.
Journal of Internal Medicine|November 6, 2025
Bioenergetics and lipid metabolism in Alzheimer's disease: From cell biology to systemic healthSilvia Maioli, Ivan Nalvarte, Maria Ankarcrona, et al.
Frontiers in Cellular Neuroscience|April 23, 2024
Impaired astrocytic synaptic function by peripheral cholesterol metabolite 27-hydroxycholesterolFokion Spanos, Gorka Gerenu, Julen Goikolea, et al.
Molecular Neurobiology|August 27, 2021
Hypercholesterolemia and 27-Hydroxycholesterol Increase S100A8 and RAGE Expression in the Brain: a Link Between Cholesterol, Alarmins, and NeurodegenerationRaúl Loera-Valencia, Muhammad-Al-Mustafa Ismail, Julen Goikolea, et al.
Brain, Behavior, and Immunity|April 12, 2024
Dynamic microglia alterations associate with hippocampal network impairments: A turning point in amyloid pathology progressionGiusy Pizzirusso, Efthalia Preka, Julen Goikolea, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
The Journal of Steroid Biochemistry and Molecular Biology|March 18, 2019
Alterations in cholesterol metabolism as a risk factor for developing Alzheimer's disease: Potential novel targets for treatmentRaúl Loera-Valencia, Julen Goikolea, Cristina Parrado-Fernandez, et al.
Journal of Virology|February 13, 2015
Triatoma virus recombinant VP4 protein induces membrane permeability through dynamic poresRubén Sánchez-Eugenia, Julen Goikolea, David Gil-Cartón, et al.
Molecular Psychiatry|September 15, 2019
Thioredoxin-80 protects against amyloid-beta pathology through autophagic-lysosomal pathway regulationGorka Gerenu, Torbjörn Persson, Julen Goikolea, et al.
The Journal of Steroid Biochemistry and Molecular Biology|August 30, 2023
Different effects of CYP27A1 and CYP7B1 on cognitive function: Two mouse models in comparisonJulen Goikolea, Maria Latorre-Leal, Christina Tsagkogianni, et al.
Alzheimer'S Research & Therapy|February 25, 2022
Serum Thioredoxin-80 is associated with age, ApoE4, and neuropathological biomarkers in Alzheimer's disease: a potential early sign of ADJulen Goikolea, Gorka Gerenu, Makrina Daniilidou, et al.
Alzheimer'S Research & Therapy|March 7, 2021
27-Hydroxycholesterol, cognition, and brain imaging markers in the FINGER randomized controlled trialAnna Sandebring-Matton, Julen Goikolea, Ingemar Björkhem, et al.
Journal of Internal Medicine|November 6, 2025
Bioenergetics and lipid metabolism in Alzheimer's disease: From cell biology to systemic healthSilvia Maioli, Ivan Nalvarte, Maria Ankarcrona, et al.
Frontiers in Cellular Neuroscience|April 23, 2024
Impaired astrocytic synaptic function by peripheral cholesterol metabolite 27-hydroxycholesterolFokion Spanos, Gorka Gerenu, Julen Goikolea, et al.
Molecular Neurobiology|August 27, 2021
Hypercholesterolemia and 27-Hydroxycholesterol Increase S100A8 and RAGE Expression in the Brain: a Link Between Cholesterol, Alarmins, and NeurodegenerationRaúl Loera-Valencia, Muhammad-Al-Mustafa Ismail, Julen Goikolea, et al.
Brain, Behavior, and Immunity|April 12, 2024
Dynamic microglia alterations associate with hippocampal network impairments: A turning point in amyloid pathology progressionGiusy Pizzirusso, Efthalia Preka, Julen Goikolea, et al.
Pageof 2